{"id":16479,"date":"2024-11-13T21:00:50","date_gmt":"2024-11-13T22:00:50","guid":{"rendered":"http:\/\/medexperts.pro\/?p=16479"},"modified":"2024-11-13T22:27:38","modified_gmt":"2024-11-13T22:27:38","slug":"ozempic-could-prevent-diabetes-should-we-use-it-for-that","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=16479","title":{"rendered":"Ozempic Could Prevent Diabetes. Should We Use It For That?"},"content":{"rendered":"
<\/div>\n

New research shows that weight loss medications can stop the progression of prediabetes. Experts don\u2019t all agree on such a use for the drugs.<\/p>\n

\n
\n
\n

A new study adds to mounting evidence showing that drugs like Ozempic don\u2019t just treat diabetes \u2014 they can also prevent it.<\/p>\n

The new paper, published Wednesday in The New England Journal of Medicine, showed that the compound in the diabetes drug Mounjaro<\/a> and the weight loss drug Zepbound<\/a> slashed by 94 percent the risk that overweight or obese adults with pre-diabetes would develop diabetes. The trial, which was funded by the drugs\u2019 maker Eli Lilly, found that most patients on the medication had their blood sugar in control after three years.<\/p>\n

Previous studies have shown that the substance<\/a> in Ozempic can have a similarly powerful effect. More than a third of American adults \u2014 roughly 98 million people \u2014 have pre-diabetes, or elevated blood sugar levels that can lead to diabetes.<\/p>\n

The question now: Are these drugs necessary?<\/p>\n

Some doctors say that these drugs should not be first line treatments for every patient with pre-diabetes, given that changes in diet and exercise are often effective for addressing the condition. There\u2019s also a question of whether insurers, who are already straining to pay for these sought-after medications, will cover them when there are other, far cheaper, treatments available.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

\u201cPotentially a lot of those same people could have had a great outcome with lifestyle intervention or with a much less expensive, much more accessible medication,\u201d said Dr. Kristina Henderson Lewis, an associate professor of epidemiology and prevention at Wake Forest University School of Medicine.<\/p>\n

\u201cJust because something works, is the most potent possible thing, doesn\u2019t mean that everybody needs it, wants it, should have it,\u201d she added.<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

New research shows that weight loss medications can stop the progression of prediabetes. Experts don\u2019t all agree on such a use for the drugs.A new study adds to mounting evidence showing that drugs like Ozempic don\u2019t just treat diabetes \u2014 they can also prevent it.The new paper, published Wednesday in The New England Journal of Medicine, showed that the compound in the diabetes drug Mounjaro and the weight loss drug Zepbound slashed by 94 percent the risk that overweight or obese adults with pre-diabetes would develop diabetes. The trial, which was funded by the drugs\u2019 maker Eli Lilly, found that most patients on the medication had their blood sugar in control after three years.Previous studies have shown that the substance in Ozempic can have a similarly powerful effect. More than a third of American adults \u2014 roughly 98 million people \u2014 have pre-diabetes, or elevated blood sugar levels that can lead to diabetes.The question now: Are these drugs necessary?Some doctors say that these drugs should not be first line treatments for every patient with pre-diabetes, given that changes in diet and exercise are often effective for addressing the condition. There\u2019s also a question of whether insurers, who are already straining to pay for these sought-after medications, will cover them when there are other, far cheaper, treatments available.\u201cPotentially a lot of those same people could have had a great outcome with lifestyle intervention or with a much less expensive, much more accessible medication,\u201d said Dr. Kristina Henderson Lewis, an associate professor of epidemiology and prevention at Wake Forest University School of Medicine.\u201cJust because something works, is the most potent possible thing, doesn\u2019t mean that everybody needs it, wants it, should have it,\u201d she added.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":16481,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-16479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lifestyle"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/16479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=16479"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/16479\/revisions"}],"predecessor-version":[{"id":16482,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/16479\/revisions\/16482"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/16481"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=16479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=16479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=16479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}